89 related articles for article (PubMed ID: 6205134)
1. Specific binding of a 125I-labeled substance P analog to rat submaxillary gland.
Bahouth SW; Stewart JM; Musacchio JM
J Pharmacol Exp Ther; 1984 Jul; 230(1):116-23. PubMed ID: 6205134
[TBL] [Abstract][Full Text] [Related]
2. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
Cascieri MA; Chicchi GG; Freidinger RM; Colton CD; Perlow DS; Williams B; Curtis NR; McKnight AT; Maguire JJ; Veber DF
Mol Pharmacol; 1986 Jan; 29(1):34-8. PubMed ID: 2418347
[TBL] [Abstract][Full Text] [Related]
3. Specific binding of [3H-Tyr8]physalaemin to rat submaxillary gland substance P receptor.
Bahouth SW; Lazaro DM; Brundish DE; Musacchio JM
Mol Pharmacol; 1985 Jan; 27(1):38-45. PubMed ID: 2578211
[TBL] [Abstract][Full Text] [Related]
4. Specific binding of [3H]substance P to the rat submaxillary gland. The effects of ions and guanine nucleotides.
Bahouth SW; Musacchio JM
J Pharmacol Exp Ther; 1985 Aug; 234(2):326-36. PubMed ID: 2410593
[TBL] [Abstract][Full Text] [Related]
5. Specific binding of an immunoreactive and biologically active 125I-labeled substance P derivative to mouse mesencephalic cells in primary culture.
Beaujouan JC; Torrens Y; Herbet A; Daguet MC; Glowinski J; Prochiantz A
Mol Pharmacol; 1982 Jul; 22(1):48-55. PubMed ID: 6181386
[TBL] [Abstract][Full Text] [Related]
6. Binding of a iodinated substance P analog to a NK-1 receptor on isolated cell membranes from rat anterior pituitary.
Larsen PJ; Mikkelsen JD; Saermark T
Endocrinology; 1989 May; 124(5):2548-57. PubMed ID: 2468475
[TBL] [Abstract][Full Text] [Related]
7. Localization and characterization of substance P binding sites in rat and rabbit eyes.
Denis P; Fardin V; Nordmann JP; Elena PP; Laroche L; Saraux H; Rostene W
Invest Ophthalmol Vis Sci; 1991 May; 32(6):1894-902. PubMed ID: 1709627
[TBL] [Abstract][Full Text] [Related]
8. 3h-substance P binding to salivary gland membranes. Regulation by guanyl nucleotides and divalent cations.
Lee CM; Javitch JA; Snyder SH
Mol Pharmacol; 1983 May; 23(3):563-9. PubMed ID: 6191191
[TBL] [Abstract][Full Text] [Related]
9. The determination of dissociation constants for substance P and substance P analogues in the guinea pig ileum by pharmacological procedures.
Lin CW; Musacchio JM
Mol Pharmacol; 1983 May; 23(3):558-62. PubMed ID: 6191190
[TBL] [Abstract][Full Text] [Related]
10. 125I-BH[Sar9, Met(O2)11]-SP, a new selective ligand for the NK-1 receptor in the central nervous system.
Tousignant C; Guillemette G; Drapeau G; Télémaque S; Dion S; Regoli D
Brain Res; 1990 Aug; 524(2):263-70. PubMed ID: 1705465
[TBL] [Abstract][Full Text] [Related]
11. Chemical cross-linking of the substance P (NK-1) receptor to the alpha subunits of the G proteins Gq and G11.
Macdonald SG; Dumas JJ; Boyd ND
Biochemistry; 1996 Mar; 35(9):2909-16. PubMed ID: 8608128
[TBL] [Abstract][Full Text] [Related]
12. Photoaffinity labeling the substance P receptor using a derivative of substance P containing p-benzoylphenylalanine.
Boyd ND; White CF; Cerpa R; Kaiser ET; Leeman SE
Biochemistry; 1991 Jan; 30(2):336-42. PubMed ID: 1703017
[TBL] [Abstract][Full Text] [Related]
13. A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative.
Beaujouan JC; Torrens Y; Viger A; Glowinski J
Mol Pharmacol; 1984 Sep; 26(2):248-54. PubMed ID: 6207421
[TBL] [Abstract][Full Text] [Related]
14. Interaction of substance P with dispersed pancreatic acinar cells from the guinea pig. Binding of radioiodinated peptide.
Sjödin L; Brodin E; Nilsson G; Conlon TP
Acta Physiol Scand; 1980 May; 109(1):97-105. PubMed ID: 6160731
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of some synthetic substance P analogs.
Chipkin RE; Stewart JM; Sweeney VE; Harris K; Williams R
Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):193-202. PubMed ID: 508003
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo studies of substance P receptor expression in rats with the new analog [indium-111-DTPA-Arg1]substance P.
Breeman WA; VanHagen MP; Visser-Wisselaar HA; van der Pluijm ME; Koper JW; Setyono-Han B; Bakker WH; Kwekkeboom DJ; Hazenberg MP; Lamberts SW; Visser TJ; Krenning EP
J Nucl Med; 1996 Jan; 37(1):108-17. PubMed ID: 8543978
[TBL] [Abstract][Full Text] [Related]
17. Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.
Walpole CS; Brown MC; James IF; Campbell EA; McIntyre P; Docherty R; Ko S; Hedley L; Ewan S; Buchheit KH; Urban LA
Br J Pharmacol; 1998 May; 124(1):83-92. PubMed ID: 9630347
[TBL] [Abstract][Full Text] [Related]
18. Internalization of [3H]substance P analogues in NK-1 receptor transfected CHO cells.
Sagan S; Lavielle S
Biochem Biophys Res Commun; 2001 Apr; 282(4):958-64. PubMed ID: 11352645
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea.
Figini M; Emanueli C; Bertrand C; Sicuteri R; Regoli D; Geppetti P
Br J Pharmacol; 1997 Jun; 121(4):773-81. PubMed ID: 9208147
[TBL] [Abstract][Full Text] [Related]
20. Rapid down-regulation of substance P binding to guinea-pig pancreatic acinar cells during homologous desensitization.
Sjödin L; Viitanen E; Gylfe E
J Physiol; 1994 Apr; 476(1):69-77. PubMed ID: 7519262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
